CADL - Candel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CADL is currently covered by 7 analysts with an average price target of $14.03. This is a potential upside of $9.13 (186.33%) from yesterday's end of day stock price of $4.9.

Candel Therapeutics's activity chart (see below) currently has 16 price targets and 28 ratings on display. The stock rating distribution of CADL is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.25% with an average time for these price targets to be met of 54.25 days.

Highest price target for CADL is $22, Lowest price target is $7, average price target is $16.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Mar-2026. First documented stock forecast 23-Aug-2021.

Currently out of the existing stock ratings of CADL, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Feb-2025

$22

$17.19 (357.38%)

$22

14 days ago
(18-Mar-2026)

0/3 (0%)

$16.96 (336.51%)

Buy Since 19-Feb-2025

$25

19 days ago
(13-Mar-2026)

0/2 (0%)

$16.53 (195.16%)

Hold Since 03-Sep-2025

$7

$2.19 (45.53%)

$15

6 months 29 days ago
(03-Sep-2025)

0/2 (0%)

$1.89 (36.99%)

Buy Since 18-Nov-2024

$19

$14.19 (295.01%)

$19

11 months 21 days ago
(11-Apr-2025)

1/5 (20%)

$14.03 (282.29%)

94

Buy Since 19-Nov-2021

$3

$-1.81 (-37.63%)

2 years 10 months 17 days ago
(15-May-2023)

1/2 (50%)

$1.4 (87.50%)

325

Show more analysts

Please expand the browser size to see the chart

What is CADL (Candel Therapeutics) average time for price targets to be met?

On average it took 54.25 days on average for the stock forecasts to be realized with a an average price target met ratio 21.25

Which analyst has the current highest performing score on CADL (Candel Therapeutics) with a proven track record?

EVAN SEIGERMAN

Which analyst has the current lower performing score on CADL (Candel Therapeutics) with a proven track record?

COLIN BRISTOW

Which analyst has the most public recommendations on CADL (Candel Therapeutics)?

Evan Seigerman works at BMO and has 31 price targets and 20 ratings on CADL

Which analyst is the currently most bullish on CADL (Candel Therapeutics)?

Chris Howerton with highest potential upside - $17.19

Which analyst is the currently most reserved on CADL (Candel Therapeutics)?

Evan Seigerman with lowest potential downside - -$1.81

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?